TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/22 15:18 | 2/28/22 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kauffman Michael | MA | D | S.d | -127 | 10.24 | 0 | -12 | -1 | 1,612 | M | |||||||||||||||
2/22/22 16:14 | 2/17/22 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kauffman Michael | MA | D | S | -220 | 12.12 | 0 | -18 | -1 | 1,603 | M | |||||||||||||||
2/9/22 17:24 | 2/7/22 | KPTI | Karyopharm Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kauffman Michael | MA | D | S | -133 | 9.86 | 0 | -13 | -1 | 1,622 | M | |||||||||||||||
1/5/22 18:51 | 1/3/22 | KZR | Kezar Life Sciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kauffman Michael | CA | D | M.d | 30 | 5.91 | 0 | 5 | 9 | 64 | D | |||||||||||||||
1/5/22 18:51 | 1/3/22 | KZR | Kezar Life Sciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kauffman Michael | CA | D | S.d | -82 | 16.45 | 0 | -5 | -7 | 64 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |